Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Bayer, Sprint Bioscience partner to develop new oncology drug candidates Bayer HealthCare has entered into a collaboration and license agreement with the Swedish company Sprint Bioscience to research, develop and commercialize oncology drug candidates. Contract Research & Services > Contract Research > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Synergy reports positive Phase III trial results of plecanatide in CIC patients
By PBR Staff Writer
US-based Synergy Pharmaceuticals has reported positive top-line results from the second of two pivotal Phase III clinical trials of plecanatide in adult patients with chronic idiopathic constipation (CIC).
Contract Research & Services > Clinical Trials > News
Astellas reports topline results from Phase III ACTIVE trial of isavuconazole in patients with candidemia
Astellas announced topline results from the Phase III ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.
Contract Research & Services > Clinical Trials > News

Contract Research

CSSi LifeSciences, PRC Clinical partner to provide extended clinical trial services
CSSi LifeSciences formalized a strategic partnership agreement with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and regulatory consulting, FDA advisory services, and patient recruitment services.
Contract Research & Services > Contract Research > News
Biogen enters strategic alliance to develop new Parkinson’s disease treatments
By PBR Staff Writer
Biogen has formed a strategic alliance with the Parkinson’s Institute and Clinical Center to improve understanding of the underlying biology of Parkinson’s disease (PD) and discover new tools and programs to accelerate research and development of new PD treatments.
Contract Research & Services > Contract Research > News

Contract Services

Regeneron, Sanofi launch new immuno-oncology collaboration
Regeneron Pharmaceuticals and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology.
Contract Research & Services > Contract Services > News
Boehringer, Hanmi to develop third generation EGFR targeted therapy in lung cancer
By PBR Staff Writer
Boehringer Ingelheim has entered into an exclusive license and collaboration agreement with Hanmi Pharmaceutical for the development and global commercialisation rights of HM61713, a new third generation EGFR targeted therapy to treat EGFR mutation positive lung cancer.
Contract Research & Services > Contract Services > News